This article was originally published on TipRanks.com Illumina, Inc.
This article was originally published on TipRanks.com Biotechnology company Illumina, Inc.
Shares of Illumina slipped 1.8% in Friday’s pre-market trading despite the gene sequencing company announcing fourth quarter earnings results that beat analysts’ expectations.
Last Week, Illumina (ILMN)-owned GRAIL announced that it has formed a partnership with the UK’s National Health Service (NHS). Starting in 2021, GRAIL’s …
Gene sequencing firm Illumina announced today the acquisition of Grail, a company focused on multi-cancer early detection, for $8 billion. Last week, a …
Genetic sequencing company Illumina is in talks to buy Grail for a price tag of more than $8 billion, according to a Bloomberg …
Illumina, Inc. (NASDAQ:ILMN) announced today that the company has filed a new patent infringement suit against Premaitha Health plc in the High Court of Justice, Chancery …
Illumina, Inc. (NASDAQ:ILMN) announced its financial results for the second quarter of fiscal year 2017.
Illumina, Inc. (NASDAQ:ILMN) and NRGene announced a collaboration to develop new molecular breeding tools for cattle.
With too many press releases to keep track of, here’s a running tab of the updates which we find most relevant for the …